Quarterly Result30 Jan 2026, 11:51 am
Hester Biosciences Q3 and 9M FY26 Results: Standalone Revenue up 12%, Profit up 140% | Consolidated Revenue up 1%, Profit up 50%
AI Summary
Hester Biosciences Limited announced the unaudited financial results for Q3 and 9M FY26. The standalone results showed that the revenue for Q3 increased by 12% and profit surged by 140%. For 9M FY26, the revenue decreased by 5% while profit increased by 16%. The consolidated results include the operations of subsidiaries in Nepal and Tanzania. Hester Nepal recorded a profit while Hester Africa reported a loss for Q3 FY26.
Key Highlights
- Standalone Q3 revenue up by 12% and profit up by 140%
- 9M standalone revenue down by 5% and profit up by 16%
- Consolidated Q3 revenue up by 1% and profit up by 50%
- Hester Nepal recorded a profit of INR 7.02 million in Q3 FY26
- Hester Africa reported a net loss of INR 38.89 million in Q3 FY26